Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Noedl

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 30, 2010
Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast AsiaHarald Noedl, Youry Se, Sabaithip Sriwichai, et al.
Plos One|December 29, 2012
Current status of artemisinin-resistant falciparum malaria in South Asia: a randomized controlled artesunate monotherapy trial in BangladeshPeter Starzengruber, Paul Swoboda, Hans-Peter Fuehrer, et al.
Plos One|November 10, 2017
A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malariaMark M Fukuda, Srivicha Krudsood, Khadeeja Mohamed, et al.
Antimicrobial Agents and Chemotherapy|November 23, 2006
In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcomeHarald Noedl, Srivicha Krudsood, Wattana Leowattana, et al.
The American Journal of Tropical Medicine and Hygiene|July 3, 2010
Indigenous Plasmodium ovale malaria in BangladeshHans-Peter Fuehrer, Peter Starzengruber, Paul Swoboda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2006
Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in ThailandHarald Noedl, Srivicha Krudsood, Kobsiri Chalermratana, et al.
Malaria Journal|September 15, 2012
Optimizing the HRP-2 in vitro malaria drug susceptibility assay using a reference clone to improve comparisons of Plasmodium falciparum field isolatesWiriya Rutvisuttinunt, Suwanna Chaorattanakawee, Stuart D Tyner, et al.
The American Journal of Tropical Medicine and Hygiene|January 15, 2014
Evidence of a major reservoir of non-malarial febrile diseases in malaria-endemic regions of BangladeshPaul Swoboda, Hans-Peter Fuehrer, Benedikt Ley, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Pharmacokinetics and pharmacodynamics of oral artesunate monotherapy in patients with uncomplicated Plasmodium falciparum malaria in western CambodiaDavid Saunders, Phisit Khemawoot, Pattaraporn Vanachayangkul, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|December 17, 2014
Plasmodium falciparum field isolates from areas of repeated emergence of drug resistant malaria show no evidence of hypermutator phenotypeTyler S Brown, Christopher G Jacob, Joana C Silva, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 30, 2010
Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast AsiaHarald Noedl, Youry Se, Sabaithip Sriwichai, et al.
Plos One|December 29, 2012
Current status of artemisinin-resistant falciparum malaria in South Asia: a randomized controlled artesunate monotherapy trial in BangladeshPeter Starzengruber, Paul Swoboda, Hans-Peter Fuehrer, et al.
Plos One|November 10, 2017
A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malariaMark M Fukuda, Srivicha Krudsood, Khadeeja Mohamed, et al.
Antimicrobial Agents and Chemotherapy|November 23, 2006
In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcomeHarald Noedl, Srivicha Krudsood, Wattana Leowattana, et al.
The American Journal of Tropical Medicine and Hygiene|July 3, 2010
Indigenous Plasmodium ovale malaria in BangladeshHans-Peter Fuehrer, Peter Starzengruber, Paul Swoboda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2006
Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in ThailandHarald Noedl, Srivicha Krudsood, Kobsiri Chalermratana, et al.
Malaria Journal|September 15, 2012
Optimizing the HRP-2 in vitro malaria drug susceptibility assay using a reference clone to improve comparisons of Plasmodium falciparum field isolatesWiriya Rutvisuttinunt, Suwanna Chaorattanakawee, Stuart D Tyner, et al.
The American Journal of Tropical Medicine and Hygiene|January 15, 2014
Evidence of a major reservoir of non-malarial febrile diseases in malaria-endemic regions of BangladeshPaul Swoboda, Hans-Peter Fuehrer, Benedikt Ley, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Pharmacokinetics and pharmacodynamics of oral artesunate monotherapy in patients with uncomplicated Plasmodium falciparum malaria in western CambodiaDavid Saunders, Phisit Khemawoot, Pattaraporn Vanachayangkul, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|December 17, 2014
Plasmodium falciparum field isolates from areas of repeated emergence of drug resistant malaria show no evidence of hypermutator phenotypeTyler S Brown, Christopher G Jacob, Joana C Silva, et al.
Pageof 9